Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines
Sanofi and Orano join forces to develop next-generation radioligand medicines
Paris, October 17, 2024.
Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into...
Zur Pressemeldung auf www.sanofi.com